What is the share price of Bayer CropScience Ltd. (Merged) (AGREVOIND)?

Company share prices are keep on changing according to the market conditions. The current trading price of Bayer CropScience Ltd. (Merged) (AGREVOIND) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Bayer CropScience . (Merged)?

The latest standalone P/E ratio of Bayer CropScience . (Merged) as of 01-Jan-1970 is 1.51.

What is the P/B ratio of Bayer CropScience Ltd. (Merged) (AGREVOIND)?

The latest standalone P/B ratio of Bayer CropScience Ltd. (Merged) (AGREVOIND) as of 01-Jan-1970 is 3.04.

What is the 52-week high and low of Bayer CropScience Ltd. (Merged) (AGREVOIND)?

The 52-week high of Bayer CropScience Ltd. (Merged) (AGREVOIND) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Bayer CropScience Ltd. (Merged) (AGREVOIND) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Bayer CropScience Ltd. (Merged) (AGREVOIND)
Brand: Bayer CropScience . (Merged)

Bayer CropScience Ltd. (Merged) (AGREVOIND) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Bayer CropScience Ltd. (Merged) (AGREVOIND)

BSE: 530415 NSE: AGREVOIND

Key Metrics

Market Cap

₹436 Cr.

P/E Ratio

1.51

Price to Book (P/B)

3.04

Price to Sales (P/S)

0.13

EV/EBITDA

-0.10

Return on Capital Employed (ROCE)

24.26%

Current Price

₹0

Return on Equity (ROE)

15.76%

Return on Assets (ROA)

12.09%

Operating Profit Margin

13.1%

Net Profit Margin

8.92%

Gross Profit Margin

14.9%

Book Value per Share

₹102.8

Sales Growth (YoY)

19.08%

Sales Growth (3 Years)

14.94%

Operating Profit Growth (1 Year)

16.5%

Operating Profit Growth (3 Years)

23.41%

Net Profit Growth (1 Year)

-75.08%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

30.06%

Dividend Yield

0.00%

Promoter Holding

67.35%

Pledged shares (%)
of Promoter's holding (%)

0.00%

DeciZen - make an informed investing decision on Bayer CropSci.(Merg)

Based on:

Data

M-Cap below 100cr DeciZen not available

Bayer CropScience Ltd. (Merged) stock performance

Key Ratios

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	TTM
ROCE % ⓘ	0%	0%	0%	0%	0%	0%	41.3%	26.2%	115%	24.3%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	2,137	2,272	2,725	3,245	3,245
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	6.3%	19.9%	19.1%	-
Adj EPS ⓘ	0	0	0	0	0	0	33.6	45.1	86.7	80.2	207.3
YoY Gr.	-	NA	NA	NA	NA	NA	NA	34%	92.4%	-7.5%	-
BVPS (₹) ⓘ	0	0	0	0	0	0	170.4	200.7	489	475.8	102.8
Adj Net Profit ⓘ	0	0	0	0	0	0	133	178	342	294	0
Cash Flow from Ops. ⓘ	0	0	0	0	0	0	122	107	138	282	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0.9	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	14.9%	19.1%
Adj EPS ⓘ	NA	NA	33.6%	-7.5%
BVPSⓘ	NA	NA	40.8%	-2.7%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	TTM
Return on Equity % ⓘ	33.4	24.3	25.1	16	71.7
Op. Profit Mgn % ⓘ	10.4	11.2	13.4	13.2	0
Net Profit Mgn % ⓘ	6.2	7.8	12.6	9.1	0
Debt to Equity ⓘ	0.2	0	0	0	-
Working Cap Days ⓘ	86	152	143	136	0
Cash Conv. Cycle ⓘ	41	63	64	62	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	207.3	-
TTM Sales (₹ Cr.)	3,245	-
BVPS (₹) ⓘ	102.8	-
Reserves (₹ Cr.) ⓘ	130	-
P/BV ⓘ	3.04	-
PE ⓘ	1.51	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	77.50 / 939.75
Market Cap (₹ Cr.)	436
Equity (₹ Cr.)	0
Face Value (₹)	10
Industry PE ⓘ	27.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Bayer CropSci.(Merg) - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Dec'01	Dec'02	Mar'11	Mar'12	Mar'13	Mar'14
Sales	432.56	308.76	2,137.30	2,272.30	2,725.30	3,245.20
Operating Expenses ⓘ +	382.45	281.82	1,914.20	2,019.60	2,365.40	2,825.90
Manufacturing Costs	9.22	9.14	35.80	38.30	53.70	59.90
Material Costs	267.07	177.54	1,375.70	1,460.60	1,745.40	2,095.60
Employee Cost	12.68	16.19	150.10	147.50	181	204
Other Costs ⓘ	93.47	78.95	352.60	373.20	385.30	466.40
Operating Profit ⓘ	50.12	26.94	223.10	252.70	359.90	419.30
Operating Profit Margin (%)	11.6%	8.7%	10.4%	11.1%	13.2%	12.9%
Other Income ⓘ +	4.68	9.16	20.50	45.30	68.90	90.90
Exceptional Items ⓘ	14.86	0.73	-3.80	-57.90	1,174.70	0
Interest ⓘ	14.76	9.24	8.30	1.70	3.70	4.80
Depreciation ⓘ	5.59	5.81	32.70	34	36.60	64.60
Profit Before Tax ⓘ	49.31	21.78	198.80	204.40	1,563.20	440.80
Tax ⓘ	18.39	7.25	67.20	65.40	401.50	151.30
Profit After Tax	30.92	14.53	131.60	139	1,161.70	289.50
PAT Margin (%)	7.2%	4.7%	6.2%	6.1%	42.6%	8.9%
Adjusted EPS (₹)	22.1	10.4	33.3	35.2	294.1	79.1
Dividend Payout Ratio (%)	18%	19%	12%	12%	2%	7%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Dec'01	Dec'02	Mar'11	Mar'12	Mar'13	Mar'14
Equity and Liabilities
Shareholders Fund +	111.99	123.37	673	792.70	1,931.30	1,742.30
Share Capital ⓘ	13.97	13.97	39.50	39.50	39.50	36.60
Reserves ⓘ	98.03	109.40	633.50	753.20	1,891.80	1,705.70
Debt +	103.33	98.56	108.50	0	0	0
Long Term Debt	103.33	98.56	0	0	0	0
Short Term Debt	0	0	108.50	0	0	0
Minority Interest	0	0	0	0	0	0
Trade Payables	63.71	44.27	295	260.50	197.20	292.10
Others Liabilities ⓘ	21.29	20.18	477.20	777.10	286.50	338.60
Total Liabilities ⓘ	300.33	286.39	1,553.70	1,830.30	2,415	2,373
Fixed Assets
Net Fixed Assets ⓘ +	47.27	45.71	347.60	247.80	218.60	227.80
Gross Block	85.86	89.35	537.70	455.70	405	469.70
Accumulated Depreciation	38.59	43.65	190.10	207.90	186.40	241.90
CWIP ⓘ	0	4.78	6.10	8.80	127.10	216.80
Investments ⓘ	0.40	0.45	3.60	3.60	3.70	3.70
Inventories	45.90	96.17	437.40	499.50	500	549.50
Trade Receivables	168.56	93.83	281.40	256.20	322.40	409.90
Cash Equivalents	14.92	15.80	363	429.90	974.10	486.20
Others Assets ⓘ	23.28	29.65	114.60	384.50	269.10	479.10
Total Assets ⓘ	300.33	286.39	1,553.70	1,830.30	2,415	2,373

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Dec'01	Dec'02	Mar'11	Mar'12	Mar'13	Mar'14
Cash Flow From Operating Activity ⓘ +	71.40	26.30	122.30	106.70	138.30	281.50
PBT ⓘ	34.44	21.04	198.80	204.40	1,563.20	440.80
Adjustment ⓘ	25.73	10.88	43	40	-1,182.60	-2.20
Changes in Working Capital ⓘ	12.8	9.83	-64	-63.7	-119.7	3.3
Tax Paid ⓘ	-15.94	-16.18	-55.50	-74	-122.60	-160.40
Cash Flow From Investing Activity ⓘ +	-3.82	-4.58	195.10	88.50	427	-289.70
Capex	-4.01	-5.18	-67.30	-49.60	645.60	-159.20
Net Investments	-0	0.04	0	0	-0.10	0
Others ⓘ	0.19	0.55	262.40	138.10	-218.50	-130.50
Cash Flow From Financing Activity ⓘ +	-53.70	-20.83	-32.40	-128.50	-21.30	-479.60
Net Proceeds from Shares ⓘ	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	1.25	0	0	0	0
Interest Paid ⓘ	-15.44	-10.49	-8.50	-1.70	-2	-1.50
Dividend Paid ⓘ	-1.67	-5.58	-15.80	-15.70	-19.30	-23.10
Others ⓘ	-36.60	-6.02	-8.10	-111.10	0	-455
Net Cash Flow ⓘ	13.88	0.88	285	66.70	544	-487.80

Finance Ratio

PARTICULARS	Dec'01	Dec'02	Mar'11	Mar'12	Mar'13	Mar'14
Ratios
ROE (%)	27.61	12.35	33.05	18.97	85.29	15.76
ROCE (%)	29.75	14.19	41.28	26.18	115.04	24.26
Asset Turnover Ratio	1.55	1.13	2.42	1.4	1.34	1.42
PAT to CFO Conversion(x)	2.31	1.81	0.93	0.77	0.12	0.97
Working Capital Days
Receivable Days	132	144	31	42	37	39
Inventory Days	36	78	44	72	64	56
Payable Days	85	108	45	69	48	43

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Bayer CropScience Ltd. (Merged) FAQs

The current trading price of Bayer CropSci.(Merg) on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Bayer CropSci.(Merg) stood at ₹436.4 Cr

The latest P/E ratio of Bayer CropSci.(Merg) as of 31-Dec-1969 is 1.51.

The latest P/B ratio of Bayer CropSci.(Merg) as of 31-Dec-1969 is 3.04.

The 52-week high of Bayer CropSci.(Merg) is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bayer CropSci.(Merg) is ₹3,245 ( Cr.) .

About Bayer CropScience Ltd. (Merged)

No data to display

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Bayer CropScience Ltd. (Merged) (AGREVOIND) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating